Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis

Arnett, 2001, TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination, Nat. Neurosci., 4, 1116, 10.1038/nn738 Barker, 2007, Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex, J. Neurosci., 27, 2948, 10.1523/JNEUROSCI.5289-06.2007 Ben Achour, 2010, Glia: the many ways to modulate synaptic plasticity, Neurochem. Int., 57, 440, 10.1016/j.neuint.2010.02.013 Benros, 2011, Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study, Am. J. Psychiatry, 168, 1303, 10.1176/appi.ajp.2011.11030516 Bowman, 1982, The copper hypothesis of schizophrenia: a review, Neurosci. Biobehav. Rev., 6, 321, 10.1016/0149-7634(82)90044-6 Coughlin, 2013, Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia, Mol. Psychiatry, 18, 10, 10.1038/mp.2012.6 Doorduin, 2009, Neuroinflammation in schizophrenia-related psychosis: a PET study, J. Nucl. Med., 50, 1801, 10.2967/jnumed.109.066647 Duan, 2010, Genome-wide approaches to schizophrenia, Brain Res. Bull., 83, 93, 10.1016/j.brainresbull.2010.04.009 Fukumoto, 2010, A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease, J. Neurosci., 30, 11157, 10.1523/JNEUROSCI.2884-10.2010 Gaier, 2013, Copper signaling in the mammalian nervous system: synaptic effects, J. Neurosci. Res., 91, 2 Garver, 2003, Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype, Neuropsychopharm., 28, 1515, 10.1038/sj.npp.1300217 Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 Gregg, 2009, Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats, Schizophr. Res., 113, 277, 10.1016/j.schres.2009.05.023 Harrison, 1999, The neuropathology of schizophrenia. A critical review of the data and their interpretation, Brain, 122, 593, 10.1093/brain/122.4.593 Herran, 2000, Higher levels of serum copper in schizophrenic patients treated with depot neuroleptics, Psychiatry Res., 94, 51, 10.1016/S0165-1781(00)00126-8 Kikawada, 2007, Trehalose transporter 1, a facilitated and high-capacity trehalose transporter, allows exogenous trehalose uptake into cells, Proc. Natl. Acad. Sci. U. S. A., 104, 11585, 10.1073/pnas.0702538104 Kopec, 2010, Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice, Biochem. Pharmacol., 80, 1407, 10.1016/j.bcp.2010.07.004 Kornhuber, 1994, Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients, Biol. Psychiatry, 36, 31, 10.1016/0006-3223(94)90059-0 Kousaka, 2009, The distribution and characterization of endogenous protein arginine N-methyltransferase 8 in mouse CNS, Neuroscience, 163, 1146, 10.1016/j.neuroscience.2009.06.061 Koutsoudaki, 2009, Demyelination of the hippocampus is prominent in the cuprizone model, Neurosci. Lett., 451, 83, 10.1016/j.neulet.2008.11.058 Kreisl, 2012, A genetic polymorphism for translocator protein 18kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation, J. Cereb. Blood Flow Metab., 33, 53, 10.1038/jcbfm.2012.131 Lin, 1998, The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6, Schizophr. Res., 32, 9, 10.1016/S0920-9964(98)00034-6 Liu, 2010, CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis, Nat. Neurosci., 13, 319, 10.1038/nn.2491 Makinodan, 2009, Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice, Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 978, 10.1016/j.pnpbp.2009.05.006 Matsushima, 2001, The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system, Brain Pathol., 11, 107, 10.1111/j.1750-3639.2001.tb00385.x Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013 Potvin, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol. Psychiatry, 63, 801, 10.1016/j.biopsych.2007.09.024 Purcell, 2009, Common polygenic variation contributes to risk of schizophrenia and bipolar disorder, Nature, 460, 748, 10.1038/nature08185 Schlief, 2006, Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus, Mol. Neurobiol., 33, 81, 10.1385/MN:33:2:81 Shi, 2009, Common variants on chromosome 6p22.1 are associated with schizophrenia, Nature, 460, 753, 10.1038/nature08192 Shore, 1983, CSF copper concentrations in chronic schizophrenia, Am. J. Psychiatry, 140, 754, 10.1176/ajp.140.6.754 Singh, 2011, Astrocytes and microglia: responses to neuropathological conditions, Int. J. Neurosci., 121, 589, 10.3109/00207454.2011.598981 Stefansson, 2009, Common variants conferring risk of schizophrenia, Nature, 460, 744, 10.1038/nature08186 van Kammen, 1999, Elevated interleukin-6 in schizophrenia, Psychiatry Res., 87, 129, 10.1016/S0165-1781(99)00053-0 Wang, 2013, Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit, Neurosci. Bull., 29, 251, 10.1007/s12264-013-1323-1 Wolf, 2006, Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia, Schizophr. Res., 86, 167, 10.1016/j.schres.2006.05.027 Xiao, 2008, Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes, Mol. Psychiatry, 13, 697, 10.1038/sj.mp.4002064 Xu, 2009, Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone, Behav. Neurosci., 123, 418, 10.1037/a0014477 Xu, 2010, Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics, Front. Behav. Neurosci., 4, 8, 10.3389/fnbeh.2010.00008 Xu, 2011, Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs, Front. Behav. Neurosci., 5, 31, 10.3389/fnbeh.2011.00031 Yang, 2009, Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia, Brain Res., 1270, 121, 10.1016/j.brainres.2009.03.011 Yanik, 2004, Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia, Biol. Trace Elem. Res., 98, 109, 10.1385/BTER:98:2:109 Yolken, 2008, Are some cases of psychosis caused by microbial agents? A review of the evidence, Mol. Psychiatry, 13, 470, 10.1038/mp.2008.5 Yoshikawa, 2011, Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage, Prostaglandins Leukot. Essent. Fat. Acids, 85, 43, 10.1016/j.plefa.2011.04.022 Zatta, 2005, Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment, Cell Mol. Life Sci., 62, 1502, 10.1007/s00018-005-5073-8 Zhang, 2008, Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse, Schizophr. Res., 106, 182, 10.1016/j.schres.2008.09.013